Biogenera Overview

  • Founded
  • 2008
Founded
  • Status
  • Public
  • Employees
  • 11
Employees

Biogenera General Information

Description

Developer of therapeutic drugs designed to provide treatment for pediatric cancer. The company's platform MyGenera is able to quickly identify and develop new drugs targeted at each specific therapeutic target consists of a single mutated considered causal gene for a disease, enabling patients to begin treatment more quickly and results in a higher likelihood of successful treatment.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • Via dell'Artigianato 2
  • Ozzano dell'Emilia
  • 40064 Bologna
  • Italy
+39 051 000 0000

Biogenera Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biogenera Financials Summary

In Thousands,
USD
TTM 31-Dec-2019 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
Revenue 435 435 927 1,298
EBITDA (359) (359) (583) (247)
Total Assets 6,852 6,852 7,211 6,852
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biogenera Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biogenera‘s full profile, request access.

Request a free trial

Biogenera Executive Team (4)

Name Title Board Seat Contact Info
Valentina Bertuccioli Ph.D Chief Executive Officer & Board Member
Andrea Pession Co-Founder
You’re viewing 2 of 4 executive team members. Get the full list »

Biogenera Board Members (4)

Name Representing Role Since
Enrico Chiapparoli Self Board Member 000 0000
Francesca Natali Self Board Member 000 0000
Massimo Tchen Self Board Member 000 0000
Valentina Bertuccioli Ph.D Biogenera Chief Executive Officer & Board Member 000 0000
To view Biogenera’s complete board members history, request access »

Biogenera Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biogenera Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biogenera‘s full profile, request access.

Request a free trial